Since US President Donald Trump – just days into his second term – began imposing tariffs on China for its role in the flow of deadly opioids like fentanyl into the United States, Beijing’s message ...

Congressman Comer says tariffs could help stop the flow of illegal drugs into the U.S. According to the DEA, China is the primary source of fentanyl that is trafficked into the U.S. The powerful ...

A drug that outperforms placebo in helping people to lose weight is one of a growing number of next-generation obesity drugs being produced in China. At first, Chinese pharmaceutical companies rushed ...

Foreign, local firms fight for market share as number of overweight or obese adults could top 630 million by 2050, from 400 ...

Out-licensing of clinical candidates from China has increased dramatically over the last five years, as the world’s pharma companies shore up their pipelines in anticipation of an approaching patent ...

The U.S. president has promised to reduce prescription drug prices by 30% to 80% for Americans, insisting they are entitled to prices paid in other developed countries. On May 12, U.S. president ...

BEIJING, May 29 (Reuters) - Bi Jingquan, former head of the now-defunct China Food and Drug Administration (CFDA), is being investigated for suspected corruption, China's anti-graft watchdog said on ...

It’s the most prescribed antibiotic in the United States, used by tens of millions of people every year to treat bacterial infections including pneumonia, stomach ulcers, and strep throat. Yet, it isn ...

SHANGHAI & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the following medicines and indications have been renewed in the 2025 National ...

Behind the scenes, major pharmaceutical companies and Trump-tied billionaires are furiously lobbying in opposite directions over proposed anti-China measures. By Rob Copeland and Rebecca Robbins Rob ...

Honghui Hu of Wanhuida Intellectual Property examines how the Supreme People’s Court has clarified the patent scope of drug combination inventions in a patent linkage dispute, offering rare guidance ...